Authors: Peter Brown
Researchers from Columbia University Medical Center (NY, USA) have treated a neonatal mouse model of hypoxic-ischemic brain injury utilizing triglyceride emulsions of docosahexaenoic acid (tri-DHA). Results indicate that treatment with tri-DHA may significantly reduce oxidative damage and improve neurological outcomes following these types of brain injury.To view restricted content, please:
To view restricted content, please: